May Faraj

Technion – Israel Institute of Technology — Israel

Medicine · Health Sciences

28h-index3.1kcitations89works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adipokines, Inflammation, and Metabolic Diseases(29), Adipose Tissue and Metabolism(27), Diabetes, Cardiovascular Risks, and Lipoproteins(19), Diet and metabolism studies(18), Lipoproteins and Cardiovascular Health(13)

Publications89 total

Knowledge and awareness of breast cancer symptoms, risk factors, and screening barriers among women in Kuwait: a cross-sectional study
BMC Women s Health·2025· 2 citedOpen Access
Rat Islet pECM Hydrogel-Based Microencapsulation: A Protective Niche for Xenotransplantation
Gels·2025Open Access
Omega-3 can help prevent diabetes and cardiovascular disease
2025
EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors
Scientific Reports·2024· 12 citedOpen Access
Corrigendum to “PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease” [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]
Metabolism·2024Open Access
EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors
2024· 1 citedOpen Access
PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
Metabolism·2023· 23 cited
Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages
Scientific Reports·2023· 9 citedOpen Access
<b>IL-6 trans-signaling is increased in diabetes, impacted by glucolipotoxicity and associated with liver stiffness and fibrosis in fatty liver disease</b>
2023Open Access
<b>IL-6 trans-signaling is increased in diabetes, impacted by glucolipotoxicity and associated with liver stiffness and fibrosis in fatty liver disease</b>
2023Open Access
IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease
Diabetes·2023· 29 citedOpen Access
Native low-density lipoproteins are priming signals of adipose tissue NLRP3 inflammasome/ interleukin-1β pathway in humans
Research Square (Research Square)·2023Open Access
PCSK7: a Novel Regulator of Apolipoprotein B and a Potential Target Against Non-Alcoholic Fatty Liver Disease
2023Open Access
Sex-Specific Models to Predict Insulin Secretion and Sensitivity in Subjects with Overweight and Obesity
International Journal of Molecular Sciences·2023· 4 citedOpen Access
The Diabetes-Related Gly482Ser Polymorphism Affects PGC1A Stability and Glucose Metabolism
Canadian Journal of Diabetes·2022
Plasma sgp130 is an independent predictor of non-alcoholic fatty liver disease severity
Journal of Hepatology·2022
Plasma sgp130 is an independent predictor of non-alcoholic fatty liver disease severity
2022· 1 citedOpen Access
Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface‐expression of LDLR and CD36 and NLRP3 inflammasome
Physiological Reports·2021· 20 citedOpen Access
White Adipose Tissue Surface Expression of LDLR and CD36 is Associated with Risk Factors for Type 2 Diabetes in Adults with Obesity
Obesity·2020· 23 cited
LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: a focus on white adipose tissue
Journal of Biomedical Research·2020· 25 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Rémi Rabasa‐Lhoret(21), Simon Bissonnette(14), Valérie Lamantia(12), Yannick Cyr(11), Hanny Wassef(8), Denis Prud’homme(7), Marie-Ève Lavoie(6), Antony D. Karelis(5), Allan D. Sniderman(5), Hubert Vidal(5), Robert Dufour(5), Alexis Baass(5), Éric Doucet(5), Jean‐Philippe Bastard(4), Martin Brochu(4), Katherine Cianflone(4), Lyne Messier(4), D. Garrel(4), Geneviève Beauregard(4), Jean Davignon(4)